Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for …

EM Jansen, SJ van de Hei, BJH Dierick… - Journal of thoracic …, 2021 - pmc.ncbi.nlm.nih.gov
Medication non-adherence to asthma and chronic obstructive pulmonary disease therapy
poses a significant burden for patients and societies. Non-adherence encompasses poor …

[HTML][HTML] Systemic corticosteroids in asthma: a call to action from World Allergy Organization and Respiratory Effectiveness Group

ER Bleecker, M Al-Ahmad, L Bjermer… - World Allergy …, 2022 - Elsevier
Systemic corticosteroids (SCS) are a highly effective treatment for acute exacerbations and
long-term symptom control in asthma. Long-term SCS use is highly prevalent across all …

Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma

H Heatley, TN Tran, A Bourdin, A Menzies-Gow… - Thorax, 2023 - thorax.bmj.com
Introduction Oral corticosteroids (OCS) for asthma are associated with increased risks of
develo** adverse outcomes (adverse outcomes); no previous study has focused …

Methods to assess COPD medications adherence in healthcare databases: a systematic review

D Vauterin, F Van Vaerenbergh… - European …, 2023 - publications.ersnet.org
Background: The Global Initiative for Chronic Obstructive Lung Disease 2023 report
recommends medication adherence assessment in COPD as an action item. Healthcare …

Over-prescription of short-acting β2-agonists and asthma management in the Gulf region: a multicountry observational study

A Alzaabi, N Al Busaidi, R Pradhan, F Shandy… - Asthma Research and …, 2022 - Springer
Background The overuse of short-acting β2-agonists (SABA) is associated with poor asthma
control. However, data on SABA use in the Gulf region are limited. Herein, we describe …

Landscape of short‐acting beta‐agonists (SABA) overuse in Europe

L de Las Vecillas, S Quirce - Clinical & Experimental Allergy, 2023 - Wiley Online Library
This review article provides an overview of short‐acting beta‐agonist (SABA) use and
prescribing trends in Europe, summarizing updated data on the results from the industry …

[HTML][HTML] SABA prescriptions and asthma management practices in patients treated by specialists in Taiwan: Results from the SABINA III study

SY Shen, CW Chen, TC Liu, CY Wang, MH Chiu… - Journal of the Formosan …, 2022 - Elsevier
Purpose Limited data exist on asthma medication patterns in Taiwan. The objectives of the
SABINA III cross-sectional study in Taiwan were thus, to describe patient demographics and …

Short-acting β2-agonist prescription patterns for asthma management in the SABINA III primary care cohort

D Price, K Hancock, J Doan, SW Taher… - NPJ Primary Care …, 2022 - nature.com
Abstract Short-acting β2-agonist (SABA) prescriptions and associated outcomes were
assessed in 1440 patients with asthma from the SABA use IN Asthma (SABINA) III study …

Highlights and recent developments in allergic diseases in EAACI journals (2019)

J Bousquet, CE Grattan, CA Akdis… - … and Translational allergy, 2020 - Springer
Abstract The European Academy of Allergy and Clinical Immunology (EAACI) owns three
journals: Allergy, Pediatric Allergy and Immunology and Clinical and Translational Allergy …

InspirerMundi—remote monitoring of inhaled medication adherence through objective verification based on combined image processing techniques

P Vieira-Marques, R Almeida… - … of Information in …, 2021 - thieme-connect.com
Background The adherence to inhaled controller medications is of critical importance for
achieving good clinical results in patients with chronic respiratory diseases. Self …